Fang Z - Search Results

1

1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.

Zhan P, Liu X, Fang Z, Pannecouque C, De Clercq E. Zhan P, et al. Among authors: fang z. Bioorg Med Chem. 2009 Sep 1;17(17):6374-9. doi: 10.1016/j.bmc.2009.07.027. Epub 2009 Jul 18. Bioorg Med Chem. 2009. PMID: 19647440

2

1,2,3-thiadiazole thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl]sulfanyl}acetanilides as HIV-1 inhibitors.

Zhan P, Liu XY, Li ZY, Fang ZJ, Pannecouque C, De Clercq E. Zhan P, et al. Chem Biodivers. 2010 Jul;7(7):1717-27. doi: 10.1002/cbdv.200900197. Chem Biodivers. 2010. PMID: 20658659

3

Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.

Zhan P, Liu X, Li Z, Fang Z, Li Z, Wang D, Pannecouque C, Clercq ED. Zhan P, et al. Among authors: fang z. Bioorg Med Chem. 2009 Aug 15;17(16):5920-7. doi: 10.1016/j.bmc.2009.07.004. Epub 2009 Jul 7. Bioorg Med Chem. 2009. PMID: 19620009

4

Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Zhan P, Liu X, Fang Z, Li Z, Pannecouque C, De Clercq E. Zhan P, et al. Among authors: fang z. Eur J Med Chem. 2009 Nov;44(11):4648-53. doi: 10.1016/j.ejmech.2009.06.037. Epub 2009 Jul 4. Eur J Med Chem. 2009. PMID: 19628308

5

Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Zhan P, Liu X, Zhu J, Fang Z, Li Z, Pannecouque C, Clercq ED. Zhan P, et al. Among authors: fang z. Bioorg Med Chem. 2009 Aug 15;17(16):5775-81. doi: 10.1016/j.bmc.2009.07.028. Epub 2009 Jul 18. Bioorg Med Chem. 2009. PMID: 19643613

6

HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.

Zhan P, Chen X, Li D, Fang Z, De Clercq E, Liu X. Zhan P, et al. Among authors: fang z. Med Res Rev. 2013 Jun;33 Suppl 1:E1-72. doi: 10.1002/med.20241. Epub 2011 Apr 26. Med Res Rev. 2013. PMID: 21523792 Review.

7

Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 update.

Song Y, Fang Z, Zhan P, Liu X. Song Y, et al. Among authors: fang z. Curr Med Chem. 2014;21(3):329-55. doi: 10.2174/09298673113206660298. Curr Med Chem. 2014. PMID: 24164196 Review.

8

Synthesis and Preliminary Antiviral Activities of Piperidine-substituted Purines against HIV and Influenza A/H1N1 Infections.

Kang D, Fang Z, Huang B, Zhang L, Liu H, Pannecouque C, Naesens L, De Clercq E, Zhan P, Liu X. Kang D, et al. Among authors: fang z. Chem Biol Drug Des. 2015 Oct;86(4):568-77. doi: 10.1111/cbdd.12520. Epub 2015 Feb 6. Chem Biol Drug Des. 2015. PMID: 25600073

9

Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.

Fang Z, Kang D, Zhang L, Huang B, Liu H, Pannecouque C, De Clercq E, Zhan P, Liu X. Fang Z, et al. Chem Biol Drug Des. 2015 Oct;86(4):614-8. doi: 10.1111/cbdd.12524. Epub 2015 Feb 19. Chem Biol Drug Des. 2015. PMID: 25626467

10

Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

Kang D, Fang Z, Li Z, Huang B, Zhang H, Lu X, Xu H, Zhou Z, Ding X, Daelemans D, De Clercq E, Pannecouque C, Zhan P, Liu X. Kang D, et al. Among authors: fang z. J Med Chem. 2016 Sep 8;59(17):7991-8007. doi: 10.1021/acs.jmedchem.6b00738. Epub 2016 Aug 26. J Med Chem. 2016. PMID: 27541578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,938 results

Search Page

Filters